These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23115539)

  • 41. Aminophylline compatibility with neonatal total parenteral nutrition.
    Sykes R; McPherson C; Foulks K; Wade J; Gal P
    J Pediatr Pharmacol Ther; 2008 Apr; 13(2):76-9. PubMed ID: 23055868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compatibility of cefazolin and gentamicin in peritoneal dialysis solutions.
    Walker PC; Kaufmann RE; Massoud N
    Drug Intell Clin Pharm; 1986 Sep; 20(9):697-700. PubMed ID: 3757783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A New Model for Non-Lipid Compounded Neonatal Parenteral Nutrition Solution Osmolality.
    Borenstein S; Mack E; Palmer K; Cat T; Gibson LC; Sandhu M; Wang J; Simmons CF
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1075-1083. PubMed ID: 30133841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Avoidance of Overt Precipitation and Patient Harm Following Errant Y-Site Administration of Calcium Chloride and Parenteral Nutrition Compounded With Sodium Glycerophosphate.
    Anderson C; Stidham C; Boehme S; Cash J
    Nutr Clin Pract; 2018 Dec; 33(6):902-905. PubMed ID: 29730898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Compatibility of propofol, fentanyl, and vecuronium mixtures designed for potential use in anesthesia and patient transport.
    Isert PR; Lee D; Naidoo D; Carasso ML; Kennedy RA
    J Clin Anesth; 1996 Jun; 8(4):329-36. PubMed ID: 8695138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration.
    Kumar A; Mann HJ
    Am J Health Syst Pharm; 2010 Oct; 67(19):1640-4. PubMed ID: 20852166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro assessment of vancomycin HCl compatibility after coinfusion with a specialized amino acid formulation.
    Martins AM; McDougal A; Hamilton D; Igwemezie L; McErlane K
    JPEN J Parenter Enteral Nutr; 1991; 15(5):536-9. PubMed ID: 1942466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Visual compatibility of 30 additives with a parenteral nutrient solution.
    Athanikar N; Boyer B; Deamer R; Harbison H; Henry RS; Jurgens R; Mett C; Sturgeon R; VanLeuven M; Welco A
    Am J Hosp Pharm; 1979 Apr; 36(4):511-3. PubMed ID: 107797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery.
    Hutchings SR; Rusho WJ; Tyler LS
    Am J Health Syst Pharm; 1996 Sep; 53(18):2185-8. PubMed ID: 8879326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion.
    Berti AD; Hutson PR; Schulz LT; Webb AP; Rose WE
    Am J Health Syst Pharm; 2015 Mar; 72(5):390-5. PubMed ID: 25694414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Compatibility considerations in parenteral nutrient solutions.
    Niemiec PW; Vanderveen TW
    Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration.
    Kidd JM; Avery LM; Asempa TE; Nicolau DP; Kuti JL
    Clin Ther; 2018 Feb; 40(2):261-269. PubMed ID: 29290374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
    Lu J; Liu Q; Kupiec TC; Vail H; Lynch LR; Fam DS; Vu NT
    Int J Pharm Compd; 2021; 25(1):52-61. PubMed ID: 33503010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physical Compatibility of Micafungin With Sodium Bicarbonate Hydration Fluids Commonly Used With High-Dose Methotrexate Chemotherapy.
    Joiner LC; Tynes C; Arnold J; Miller RR; Gorman G
    Hosp Pharm; 2018 Apr; 53(2):125-127. PubMed ID: 29581608
    [No Abstract]   [Full Text] [Related]  

  • 56. Y-Site Physical Compatibility of Numeta G13E with Drugs Frequently Used at Neonatal Intensive Care.
    Nezvalova-Henriksen K; Nilsson N; Østerberg CT; Staven Berge V; Tho I
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32708409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stability of cefodizime in solution and compatibility with other injectable drugs.
    Merighi M; Carlotto A; Guella L; Bonora S; Fibbia GC; Mazzi R; Lazzarini L; Mirandola F; Cruciani M; Concia E
    J Chemother; 1994 Aug; 6(4):243-5. PubMed ID: 7830101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physical and chemical compatibility of daptomycin with nine medications.
    Lai JJ; Brodeur SK
    Ann Pharmacother; 2004 Oct; 38(10):1612-6. PubMed ID: 15328397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wastage of standardised parenteral nutrition solution - a challenge for neonatal units.
    Deshmukh M; Grzejszczyk J; Mehta S; Patole S
    J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3088-3091. PubMed ID: 29606021
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of Y-site compatibility of home total parenteral nutrition and intravenous loop diuretics.
    Watrobska-Swietlikowska D; Pietka M; Klek S
    Medicine (Baltimore); 2019 May; 98(21):e15747. PubMed ID: 31124957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.